CA Stock MarketDetailed Quotes

OMND Optimind Pharma Corp

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayTrading Oct 31 12:57 ET
521.94KMarket Cap-714P/E (TTM)

Optimind Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)May 31, 2024
(FY)Feb 29, 2024
(Q4)Feb 29, 2024
(Q3)Nov 30, 2023
(Q2)Aug 31, 2023
(Q1)May 31, 2023
(FY)Feb 28, 2023
(Q4)Feb 28, 2023
(Q3)Nov 30, 2022
(Q2)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
-1.04M
-159.06K
-308.45K
-1,515.01%-435.94K
Net income from continuing operations
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
67.02%-104.42K
71.75%-183.5K
-214.14%-403.66K
---3.08M
---1.98M
---316.61K
-3,396.60%-649.51K
Operating gains losses
----
----
----
----
----
----
----
----
--0
----
Depreciation and amortization
--0
-54.39%19.95K
--0
-54.39%4.99K
-31.58%7.48K
-31.58%7.48K
--43.74K
--10.94K
--10.94K
--10.94K
Asset impairment expenditure
----
-68.93%564.61K
----
----
----
----
--1.82M
----
----
----
Remuneration paid in stock
--0
--162.4K
--0
--0
--0
--162.4K
--0
--0
--0
--0
Deferred tax
----
1.02%-8.76K
-52.22%-8.76K
--0
----
----
---8.85K
---5.75K
--0
--0
Other non cashItems
----
-73.27%83.86K
-94.05%16.92K
-38.20%8.9K
219.55%28.97K
392.60%29.08K
--313.7K
--284.33K
--14.4K
216.76%9.07K
Change In working capital
648.34%214.91K
181.96%105.25K
770.55%130.07K
584.21%83.21K
0.34%-68.83K
-72.13%-39.19K
---128.41K
---19.4K
---17.18K
-286.77%-69.06K
-Change in receivables
585.07%108.08K
57.88%-43.9K
92.20%-5.72K
132.37%7.51K
-252.56%-23.41K
3.66%-22.28K
---104.24K
---73.27K
---23.18K
--15.34K
-Change in payables and accrued expense
731.71%106.83K
716.95%149.15K
152.05%135.78K
1,161.70%75.7K
46.19%-45.42K
-4,823.74%-16.91K
---24.18K
--53.87K
--6K
---84.41K
Cash from discontinued investing activities
Operating cash flow
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
---1.04M
---159.06K
---308.45K
-1,515.01%-435.94K
Investing cash flow
Cash flow from continuing investing activities
0
89.63%-22.86K
99.67%-212
55.44%-15.6K
95.94%-3.05K
91.21%-4K
-220.5K
-65K
-35K
-75K
Net business purchase and sale
--0
--0
-78.54%22.65K
55.44%-15.6K
95.94%-3.05K
91.21%-4K
---50K
--105.5K
---35K
---75K
Net other investing changes
----
86.59%-22.86K
----
----
----
----
---170.5K
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
89.63%-22.86K
99.67%-212
55.44%-15.6K
95.94%-3.05K
91.21%-4K
---220.5K
---65K
---35K
---75K
Financing cash flow
Cash flow from continuing financing activities
0
32.53%-30.4K
0
33.33%-7.6K
0.00%-11.4K
-5.00%-11.4K
-45.06K
-11.4K
-11.4K
-145.95%-11.4K
Net issuance payments of debt
--0
32.53%-30.4K
--0
33.33%-7.6K
0.00%-11.4K
0.00%-11.4K
---45.06K
---10.86K
---11.4K
-145.95%-11.4K
Net other financing activities
----
----
----
----
----
----
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
32.53%-30.4K
--0
33.33%-7.6K
0.00%-11.4K
-5.00%-11.4K
---45.06K
---11.4K
---11.4K
-145.95%-11.4K
Net cash flow
Beginning cash position
-94.80%28.7K
-70.29%552.22K
-95.93%32.08K
-94.52%62.6K
-82.41%292.93K
-70.29%552.22K
--1.86M
--787.68K
--1.14M
50,895.61%1.66M
Current changes in cash
145.28%117.41K
59.93%-523.52K
98.56%-3.39K
91.40%-30.52K
55.91%-230.33K
-33.74%-259.29K
---1.31M
---235.46K
---354.85K
-23,808.52%-522.34K
End cash Position
-50.12%146.1K
-94.80%28.7K
-94.80%28.7K
-95.93%32.08K
-94.52%62.6K
-82.41%292.93K
--552.22K
--552.22K
--787.68K
130,601.61%1.14M
Free cash from
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
50.48%-215.88K
-77.35%-243.89K
---1.04M
---159.06K
---308.45K
-1,515.01%-435.94K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)May 31, 2024(FY)Feb 29, 2024(Q4)Feb 29, 2024(Q3)Nov 30, 2023(Q2)Aug 31, 2023(Q1)May 31, 2023(FY)Feb 28, 2023(Q4)Feb 28, 2023(Q3)Nov 30, 2022(Q2)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K-1.04M-159.06K-308.45K-1,515.01%-435.94K
Net income from continuing operations 75.85%-97.5K54.60%-1.4M64.41%-706.01K67.02%-104.42K71.75%-183.5K-214.14%-403.66K---3.08M---1.98M---316.61K-3,396.60%-649.51K
Operating gains losses ----------------------------------0----
Depreciation and amortization --0-54.39%19.95K--0-54.39%4.99K-31.58%7.48K-31.58%7.48K--43.74K--10.94K--10.94K--10.94K
Asset impairment expenditure -----68.93%564.61K------------------1.82M------------
Remuneration paid in stock --0--162.4K--0--0--0--162.4K--0--0--0--0
Deferred tax ----1.02%-8.76K-52.22%-8.76K--0-----------8.85K---5.75K--0--0
Other non cashItems -----73.27%83.86K-94.05%16.92K-38.20%8.9K219.55%28.97K392.60%29.08K--313.7K--284.33K--14.4K216.76%9.07K
Change In working capital 648.34%214.91K181.96%105.25K770.55%130.07K584.21%83.21K0.34%-68.83K-72.13%-39.19K---128.41K---19.4K---17.18K-286.77%-69.06K
-Change in receivables 585.07%108.08K57.88%-43.9K92.20%-5.72K132.37%7.51K-252.56%-23.41K3.66%-22.28K---104.24K---73.27K---23.18K--15.34K
-Change in payables and accrued expense 731.71%106.83K716.95%149.15K152.05%135.78K1,161.70%75.7K46.19%-45.42K-4,823.74%-16.91K---24.18K--53.87K--6K---84.41K
Cash from discontinued investing activities
Operating cash flow 148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K---1.04M---159.06K---308.45K-1,515.01%-435.94K
Investing cash flow
Cash flow from continuing investing activities 089.63%-22.86K99.67%-21255.44%-15.6K95.94%-3.05K91.21%-4K-220.5K-65K-35K-75K
Net business purchase and sale --0--0-78.54%22.65K55.44%-15.6K95.94%-3.05K91.21%-4K---50K--105.5K---35K---75K
Net other investing changes ----86.59%-22.86K-------------------170.5K------------
Cash from discontinued investing activities
Investing cash flow --089.63%-22.86K99.67%-21255.44%-15.6K95.94%-3.05K91.21%-4K---220.5K---65K---35K---75K
Financing cash flow
Cash flow from continuing financing activities 032.53%-30.4K033.33%-7.6K0.00%-11.4K-5.00%-11.4K-45.06K-11.4K-11.4K-145.95%-11.4K
Net issuance payments of debt --032.53%-30.4K--033.33%-7.6K0.00%-11.4K0.00%-11.4K---45.06K---10.86K---11.4K-145.95%-11.4K
Net other financing activities ----------------------------------0--0
Cash from discontinued financing activities
Financing cash flow --032.53%-30.4K--033.33%-7.6K0.00%-11.4K-5.00%-11.4K---45.06K---11.4K---11.4K-145.95%-11.4K
Net cash flow
Beginning cash position -94.80%28.7K-70.29%552.22K-95.93%32.08K-94.52%62.6K-82.41%292.93K-70.29%552.22K--1.86M--787.68K--1.14M50,895.61%1.66M
Current changes in cash 145.28%117.41K59.93%-523.52K98.56%-3.39K91.40%-30.52K55.91%-230.33K-33.74%-259.29K---1.31M---235.46K---354.85K-23,808.52%-522.34K
End cash Position -50.12%146.1K-94.80%28.7K-94.80%28.7K-95.93%32.08K-94.52%62.6K-82.41%292.93K--552.22K--552.22K--787.68K130,601.61%1.14M
Free cash from 148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K50.48%-215.88K-77.35%-243.89K---1.04M---159.06K---308.45K-1,515.01%-435.94K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data